3 ms·
User acquisition is a big thing. There are loads of people (including doctors) who lean on brand name drugs when generics are available and it's largely about t
by tootie 4y ago
User acquisition is a big thing. There are loads of people (including doctors) who lean on brand name drugs when generics are available and it's largely about that brand. Drug names are obscure and drug brands become trusted. If Cuban can successfully build a brand with a lot of awareness then that has the potential to uplift the entire generics market. Even if the actual mechanics of the business are nothing special.
- jonathan-adly 4y agoIt doesn't quite work like that in pharmacy! 1. Your insurance can and will block certain pharmacies if they got big enough (see PillPack before the Amazon acquisition). They have their own pharmacies and route the most profitable scripts there. 2. You would run into market size limitation if you decide to never accept insurance 3. Getting someone to switch their pharmacy requires major effort on their part - as well as the cooperation of all their doctors. It's almost like switching IT vendors!!